WO2026067668 - ANTI-IL-17 ANTIBODY FORMULATION, AND PREPARATION METHOD AND USE THEREFOR
National phase entry is expected:
Publication Number
WO/2026/067668
Publication Date
02.04.2026
International Application No.
PCT/CN2025/124559
International Filing Date
26.09.2025
Title **
[English]
ANTI-IL-17 ANTIBODY FORMULATION, AND PREPARATION METHOD AND USE THEREFOR
[French]
FORMULATION D'ANTICORPS ANTI-IL-17, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
抗IL-17抗体制剂及其制备方法和应用
Applicants **
BIO-THERA SOLUTIONS, LTD.
Inventors
LI, Qingrui
ZHANG, Weixiao
WU, Yong
LI, Qinying
Priority Data
202411368507.2
27.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2734 | |
| EPO | Filing, Examination, Granting | 29515 | |
| Japan | Filing, Examination, Granting | 3233 | |
| South Korea | Filing, Examination, Granting | 4450 | |
| USA | Filing, Examination, Granting | 10740 |
Total:
50,672
Contact Us
Abstract[English]
The present application belongs to the field of biological formulations, and provides a formulation comprising an anti-IL-17 antibody. The antibody formulation has good stability under high temperature and illumination, can be stored in liquid form, and is convenient to use.[French]
La présente demande appartient au domaine des formulations biologiques et concerne une formulation comprenant un anticorps anti-IL-17. La formulation d'anticorps présente une bonne stabilité à température élevée et sous illumination, peut être conservée sous forme liquide et est pratique à utiliser.[Chinese]
属于生物制剂领域，提供包括抗IL-17抗体的制剂。抗体制剂在高温和光照下均具有良好的稳定性，能够以液态形式保存，方便使用。